drugset / Trial / NCT02354885
TXA in the EMS on the Helicopter and the Ambulance
Phase 4
Unknown
50 enrolled
University of Zurich
Cantonal Hospital of St. Gallen · collabLuzerner Kantonsspital · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Coagulopathy in trauma increases mortality and morbidity. Early administration of tranexamic acid (TXA) seems to improve survival and outcome. Thus this study evaluates the administration of TXA on scene by the emergency medical services (EMS) or by the crew of a rescue helicopter in multiple trauma patients or isolated traumatic brain injury (TBI). Coagulopathy will be assessed by standard laboratory tests as well as thromboelastometry.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 1 g | Intravenous |